Cargando…
TP53 Status and Response to Treatment in Breast Cancers
The p53 wild-type protein plays an important role in cells as is shown by its fine regulation at different levels. Since its discovery, numerous mutations have been described. In breast cancers, p53 is mutated in almost 30% of cases, with a higher frequency in some tumor subtypes. TP53 mutation is r...
Autores principales: | Varna, Mariana, Bousquet, Guilhem, Plassa, Louis-François, Bertheau, Philippe, Janin, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114547/ https://www.ncbi.nlm.nih.gov/pubmed/21760703 http://dx.doi.org/10.1155/2011/284584 |
Ejemplares similares
-
Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma
por: Bousquet, Guilhem, et al.
Publicado: (2015) -
Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen
por: Bertheau, Philippe, et al.
Publicado: (2007) -
Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients
por: Verneuil, Laurence, et al.
Publicado: (2015) -
Changes in allelic imbalances in locally advanced breast cancers after chemotherapy
por: Varna, M, et al.
Publicado: (2007) -
Individual xenograft as a personalized therapeutic resort for women with metastatic triple-negative breast carcinoma
por: Bousquet, Guilhem, et al.
Publicado: (2014)